5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide

C143H146Cl2N42O13S2 — CID 159683021

IUPAC5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide
SMILESCOc1ccc(Cl)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.CSc1ncc(Cl)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)n1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1CCNCC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccc(-c2ccccc2)c1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cn2ccsc2n1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ncccc1CCc1ccccc1
InChIInChI=1S/C29H29N7O2.C28H26N6O2.C23H23ClN6O3.C21H21ClN8O2S.C21H20N8O2S.C21H27N7O2/c37-29(26-22(7-4-12-30-26)10-8-20-5-2-1-3-6-20)34-25-18-31-35-27(25)28-32-23-11-9-21(17-24(23)33-28)19-36-13-15-38-16-14-36;35-28(22-8-4-7-21(16-22)20-5-2-1-3-6-20)32-25-17-29-33-26(25)27-30-23-10-9-19(15-24(23)31-27)18-34-11-13-36-14-12-34;1-32-20-5-3-15(24)11-16(20)23(31)28-19-12-25-29-21(19)22-26-17-4-2-14(10-18(17)27-22)13-30-6-8-33-9-7-30;1-33-21-23-9-13(22)17(28-21)20(31)27-16-10-24-29-18(16)19-25-14-3-2-12(8-15(14)26-19)11-30-4-6-32-7-5-30;30-20(17-12-29-5-8-32-21(29)26-17)25-16-10-22-27-18(16)19-23-14-2-1-13(9-15(14)24-19)11-28-3-6-31-7-4-28;29-21(15-3-5-22-6-4-15)26-18-12-23-27-19(18)20-24-16-2-1-14(11-17(16)25-20)13-28-7-9-30-10-8-28/h1-7,9,11-12,17-18H,8,10,13-16,19H2,(H,31,35)(H,32,33)(H,34,37);1-10,15-17H,11-14,18H2,(H,29,33)(H,30,31)(H,32,35);2-5,10-12H,6-9,13H2,1H3,(H,25,29)(H,26,27)(H,28,31);2-3,8-10H,4-7,11H2,1H3,(H,24,29)(H,25,26)(H,27,31);1-2,5,8-10,12H,3-4,6-7,11H2,(H,22,27)(H,23,24)(H,25,30);1-2,11-12,15,22H,3-10,13H2,(H,23,27)(H,24,25)(H,26,29)
InChIKeyMVLAPMVFIOMHFC-UHFFFAOYSA-N
MW2796.06 g/mol
LogP20.29
Rot. Bonds36

About 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide

5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide (PubChem CID 159683021) has the molecular formula C143H146Cl2N42O13S2 and a molecular weight of 2796.06 g/mol. Its IUPAC name is 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide.

Molecular Properties

Compound Name5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide
PubChem CID159683021
Molecular FormulaC143H146Cl2N42O13S2
Molecular Weight2796.06 g/mol
Exact Mass2793.09
IUPAC Name5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide
SMILESCOc1ccc(Cl)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.CSc1ncc(Cl)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)n1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1CCNCC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccc(-c2ccccc2)c1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cn2ccsc2n1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ncccc1CCc1ccccc1
InChIInChI=1S/C29H29N7O2.C28H26N6O2.C23H23ClN6O3.C21H21ClN8O2S.C21H20N8O2S.C21H27N7O2/c37-29(26-22(7-4-12-30-26)10-8-20-5-2-1-3-6-20)34-25-18-31-35-27(25)28-32-23-11-9-21(17-24(23)33-28)19-36-13-15-38-16-14-36;35-28(22-8-4-7-21(16-22)20-5-2-1-3-6-20)32-25-17-29-33-26(25)27-30-23-10-9-19(15-24(23)31-27)18-34-11-13-36-14-12-34;1-32-20-5-3-15(24)11-16(20)23(31)28-19-12-25-29-21(19)22-26-17-4-2-14(10-18(17)27-22)13-30-6-8-33-9-7-30;1-33-21-23-9-13(22)17(28-21)20(31)27-16-10-24-29-18(16)19-25-14-3-2-12(8-15(14)26-19)11-30-4-6-32-7-5-30;30-20(17-12-29-5-8-32-21(29)26-17)25-16-10-22-27-18(16)19-23-14-2-1-13(9-15(14)24-19)11-28-3-6-31-7-4-28;29-21(15-3-5-22-6-4-15)26-18-12-23-27-19(18)20-24-16-2-1-14(11-17(16)25-20)13-28-7-9-30-10-8-28/h1-7,9,11-12,17-18H,8,10,13-16,19H2,(H,31,35)(H,32,33)(H,34,37);1-10,15-17H,11-14,18H2,(H,29,33)(H,30,31)(H,32,35);2-5,10-12H,6-9,13H2,1H3,(H,25,29)(H,26,27)(H,28,31);2-3,8-10H,4-7,11H2,1H3,(H,24,29)(H,25,26)(H,27,31);1-2,5,8-10,12H,3-4,6-7,11H2,(H,22,27)(H,23,24)(H,25,30);1-2,11-12,15,22H,3-10,13H2,(H,23,27)(H,24,25)(H,26,29)
InChIKeyMVLAPMVFIOMHFC-UHFFFAOYSA-N
XLogP20.29
TPSA670.81 Ų
H-Bond Donors19
H-Bond Acceptors39
Rotatable Bonds36
Heavy Atoms202
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002796.06
LogP ≤ 520.29
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1039

Analyze 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide?
The IUPAC name of 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide (CID 159683021) is 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide.
What is the SMILES notation for 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide?
The canonical SMILES for 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide is COc1ccc(Cl)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.CSc1ncc(Cl)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)n1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1CCNCC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccc(-c2ccccc2)c1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cn2ccsc2n1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ncccc1CCc1ccccc1.
What is the InChIKey of 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide?
The InChIKey is MVLAPMVFIOMHFC-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H29N7O2.C28H26N6O2.C23H23ClN6O3.C21H21ClN8O2S.C21H20N8O2S.C21H27N7O2/c37-29(26-22(7-4-12-30-26)10-8-20-5-2-1-3-6-20)34-25-18-31-35-27(25)28-32-23-11-9-21(17-24(23)33-28)19-36-13-15-38-16-14-36;35-28(22-8-4-7-21(16-22)20-5-2-1-3-6-20)32-25-17-29-33-26(25)27-30-23-10-9-19(15-24(23)31-27)18-34-11-13-36-14-12-34;1-32-20-5-3-15(24)11-16(20)23(31)28-19-12-25-29-21(19)22-26-17-4-2-14(10-18(17)27-22)13-30-6-8-33-9-7-30;1-33-21-23-9-13(22)17(28-21)20(31)27-16-10-24-29-18(16)19-25-14-3-2-12(8-15(14)26-19)11-30-4-6-32-7-5-30;30-20(17-12-29-5-8-32-21(29)26-17)25-16-10-22-27-18(16)19-23-14-2-1-13(9-15(14)24-19)11-28-3-6-31-7-4-28;29-21(15-3-5-22-6-4-15)26-18-12-23-27-19(18)20-24-16-2-1-14(11-17(16)25-20)13-28-7-9-30-10-8-28/h1-7,9,11-12,17-18H,8,10,13-16,19H2,(H,31,35)(H,32,33)(H,34,37);1-10,15-17H,11-14,18H2,(H,29,33)(H,30,31)(H,32,35);2-5,10-12H,6-9,13H2,1H3,(H,25,29)(H,26,27)(H,28,31);2-3,8-10H,4-7,11H2,1H3,(H,24,29)(H,25,26)(H,27,31);1-2,5,8-10,12H,3-4,6-7,11H2,(H,22,27)(H,23,24)(H,25,30);1-2,11-12,15,22H,3-10,13H2,(H,23,27)(H,24,25)(H,26,29).
What are the key properties of 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide?
5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide has a molecular weight of 2796.06 g/mol, XLogP of 20.29, 36 rotatable bonds, 19 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 5-chloro-2-methoxy-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;5-chloro-2-methylsulfanyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyrimidine-4-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]imidazo[2,1-b][1,3]thiazole-6-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(2-phenylethyl)pyridine-2-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]piperidine-4-carboxamide is sourced from PubChem (CID 159683021), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).